Bridgeway Capital Management’s Larimar Therapeutics LRMR Stock Holding History

Bridgeway Capital Management’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$298K	Hold	103,216	–	–	0.01%	864
2025 Q1	$222K	Buy	+103,216	New	+$222K	0.01%	905
2024 Q2	–	Sell	-84,500	Closed	-$641K	–	1310
2024 Q1	$641K	Sell	84,500 -35,000	-29%	-$266K	0.01%	856
2023 Q4	$544K	Buy	119,500 +6,700	+6%	+$30.5K	0.01%	918
2023 Q3	$446K	Sell	112,800 -25,000	-18%	-$98.8K	0.01%	911
2023 Q2	$431K	Hold	137,800	–	–	0.01%	944
2023 Q1	$624K	Buy	137,800 +75,000	+119%	+$340K	0.02%	831
2022 Q4	$259K	Sell	62,800 -58,799	-48%	-$243K	0.01%	1023
2022 Q3	$389K	Hold	121,599	–	–	0.01%	959
2022 Q2	$238K	Buy	121,599 +58,799	+94%	+$115K	0.01%	1052
2022 Q1	$254K	Hold	62,800	–	–	﹤0.01%	1120
2021 Q4	$678K	Buy	+62,800	New	+$678K	0.01%	894
2021 Q2	–	Sell	-20,000	Closed	-$292K	–	1370
2021 Q1	$292K	Buy	+20,000	New	+$292K	0.01%	1228
2020 Q4	–	Sell	-10,250	Closed	-$155K	–	1344
2020 Q3	$155K	Buy	+10,250	New	+$155K	﹤0.01%	1211
2020 Q2	–	Sell	-3,750	Closed	-$35K	–	1357
2020 Q1	$35K	Buy	+3,750	New	+$35K	﹤0.01%	1241
2019 Q4	–	Sell	-3,675	Closed	-$33K	–	1360
2019 Q3	$33K	Hold	3,675	–	–	﹤0.01%	1290
2019 Q2	$52K	Sell	3,675 -5,428	-60%	-$76.8K	﹤0.01%	1277
2019 Q1	$299K	Buy	9,103 +642	+8%	+$21.1K	﹤0.01%	1154
2018 Q4	$503K	Hold	8,461	–	–	0.01%	1000
2018 Q3	$1.19M	Hold	8,461	–	–	0.01%	813
2018 Q2	$1.04M	Hold	8,461	–	–	0.01%	869
2018 Q1	$756K	Buy	8,461 +91	+1%	+$8.13K	0.01%	941
2017 Q4	$464K	Sell	8,370 -6,195	-43%	-$343K	0.01%	1114
2017 Q3	$615K	Hold	14,565	–	–	0.01%	1033
2017 Q2	$614K	Buy	14,565 +7,119	+96%	+$300K	0.01%	1025
2017 Q1	$416K	Sell	7,446 -15,108	-67%	-$844K	0.01%	1119
2016 Q4	$861K	Sell	22,554 -471	-2%	-$18K	0.01%	871
2016 Q3	$915K	Hold	23,025	–	–	0.01%	836
2016 Q2	$1.66M	Buy	+23,025	New	+$1.66M	0.03%	601